TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancersEleonora Ghisoni, Giorgio Valabrega|Journal of Ovarian Research|2019Cited by 33
Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancerJessica Erriquez, Giorgio Valabrega|Oncotarget|2016Cited by 16